Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination

References

• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020;383(19):1813–1826. doi:10.1056/NEJMoa2007764
   PubMed Web of Science ®Google Scholar
• Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704.
   PubMed Web of Science ®Google Scholar
• Schmelz K, Bowles S. Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out. Proc Natl Acad Sci U S A. 2021;118(25):e34.
   Web of Science ®Google Scholar
• Wouters O, Shadlen K, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–1034. doi:10.1016/S0140-6736(21)00306-8
   PubMed Web of Science ®Google Scholar
• Carlson N, Nelveg-Kristensen K, Freese Ballegaard E, et al. Increased vulnerability to COVID-19 in chronic kidney disease. J Intern Med. 2021;290(1):166–178. doi:10.1111/joim.13239
   PubMed Web of Science ®Google Scholar
• Henry B, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52(6):1193–1194. doi:10.1007/s11255-020-02451-9
   PubMed Web of Science ®Google Scholar
• Hsu Caroline M, Weiner Daniel E, Aweh G, et al. COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider. Am J Kidney Dis. 2021;77(5):748–756.e1. doi:10.1053/j.ajkd.2021.01.003
   PubMed Web of Science ®Google Scholar
• Longlune N, Nogier MB, Miedougé M, et al. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021;36(9):1704–1709. doi:10.1093/ndt/gfab193
   PubMed Web of Science ®Google Scholar
• Grupper A, Sharon N, Finn T, et al. Humoral response to the pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. 2021;16(7):1037–1042. doi:10.2215/CJN.03500321
   PubMed Web of Science ®Google Scholar
• Popmihajlov Z, Pang L, Brown E, et al. A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL). Hum Vaccin Immunother. 2018;14(12):2916–2920. doi:10.1080/21645515.2018.1502517
   PubMed Web of Science ®Google Scholar
• Simon B, Rubey H, Treipl A, et al. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls. Nephrol Dial Transplant. 2021;36:1709–1716. doi:10.1093/ndt/gfab179
   PubMed Web of Science ®Google Scholar
• Randolph H, Barreiro L. Herd immunity: understanding COVID-19. Immunity. 2020;52(5):737–741. doi:10.1016/j.immuni.2020.04.012
   PubMed Web of Science ®Google Scholar
• Kwok K, Lai F, Wei W, Wong S, Tang J. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. J Infection. 2020;80(6):e32–e33. doi:10.1016/j.jinf.2020.03.027
   PubMed Web of Science ®Google Scholar
• Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):77–81. doi:10.1126/science.abc1932
   PubMed Web of Science ®Google Scholar
• Wang X, Guo X, Xin Q, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clin Infect Dis. 2020;71(10):2688–2694. doi:10.1093/cid/ciaa721
   PubMed Web of Science ®Google Scholar
• Doroftei B, Ciobica A, Ilie O, Maftei R, Ilea C. Mini-review discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics. 2021;11(4):579. doi:10.3390/diagnostics11040579
   Web of Science ®Google Scholar
• Beilhack G, Monteforte R, Frommlet F, Gaggl M, Strassl R, Vychytil A. Antibody response and safety after mRNA-1273 SARS-CoV-2 vaccination in peritoneal dialysis patients - the Vienna cohort. Front Immunol. 2021;12:780594. doi:10.3389/fimmu.2021.780594
   PubMed Web of Science ®Google Scholar
• Terpos E, Trougakos I, Apostolakou F, et al. Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine. Am J Hematol. 2021;96(7):E257–E259. doi:10.1002/ajh.26185
   PubMed Web of Science ®Google Scholar
• Abu Jabal K, Ben-Amram H, Beiruti K, et al. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Euro Surveill. 2021;26(6). doi:10.2807/1560-7917.ES.2021.26.6.2100096
   PubMedGoogle Scholar
• Yau K, Abe K, Naimark D, et al. Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis. JAMA netw open. 2021;4(9):e2123622. doi:10.1001/jamanetworkopen.2021.23622
   PubMed Web of Science ®Google Scholar
• Jara A, Undurraga E, González C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385(10):875–884. doi:10.1056/NEJMoa2107715
   PubMed Web of Science ®Google Scholar
• Boongird S, Chuengsaman P, Setthaudom C, et al. Short-term immunogenicity profiles and predictors for suboptimal immune responses in patients with end-stage kidney disease immunized with inactivated SARS-CoV-2 vaccine. Infect Dis Ther. 2022;11(1):351–365. doi:10.1007/s40121-021-00574-9
   PubMed Web of Science ®Google Scholar
• Yen J, Wang I, Yen T. COVID-19 vaccination & dialysis patients: why the variable response. QJM. 2021;114(7):440–444. doi:10.1093/qjmed/hcab171
   PubMed Web of Science ®Google Scholar
• Speer C, Goth D, Benning L, et al. Early humoral responses of hemodialysis patients after COVID-19 vaccination with BNT162b2. Clin J Am Soc Nephrol. 2021;16(7):1073–1082. doi:10.2215/CJN.03700321
   PubMed Web of Science ®Google Scholar
• Murin C, Wilson I, Ward A. Antibody responses to viral infections: a structural perspective across three different enveloped viruses. Nature Microbiol. 2019;4(5):734–747. doi:10.1038/s41564-019-0392-y
   PubMed Web of Science ®Google Scholar
• Jalkanen P, Kolehmainen P, Häkkinen H, et al. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat commun. 2021;12(1):3991. doi:10.1038/s41467-021-24285-4
   PubMed Web of Science ®Google Scholar
• Agur T, Ben-Dor N, Goldman S, et al. Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients - a prospective cohort study. Nephrol Dial Transpl. 2021;36:1347–1349. doi:10.1093/ndt/gfab155
   Web of Science ®Google Scholar